Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Endocrinology > Disorders of Multiple Endocrine Glands > Flashcards

Disorders of Multiple Endocrine Glands Flashcards

1
Q

MEN I - Wermer’s Syndrome Affects what

A

The 3 Ps

Pituitary
Parathyroid
Pancreas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is multiple endocrine neoplasm and what is its inheritance pattern

A
  • neoplastic syndromes involving multiple endocrine glands
  • tumours of neuroectodermal origin
  • autosomal dominant inheritance with variable penetrance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What investigation has long-term benefit in MEN II

A

genetic screening for RET proto-oncogene on chromosome 10 has long-term benefit in MEN II

■ early cure and prevention of medullary thyroid cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MEN Classification types

A

MEN I (chromosome 11) - Wermer’s Syndrome

MEN II (chromosome 10)

  1. IIa Sipple’s Syndrome
  2. Familial Medullary Thyroid Ca (a variant of IIa)
  3. IIb
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Wermer’s Syndrome tissues involved

A

Pituitary (15-42%)
Anterior pituitary adenoma

Parathyroid (≥95%)
Primary hyperparathyroidism from hyperplasia

Entero-pancreatic endocrine (30-80%) 
Pancreatic islet cell tumours 
Gastrinoma 
Insulinomas 
Vasoactive intestinal peptide 
(VIP)-omas 
Glucagonoma 
Carcinoid syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Wermer’s Syndrome clinical manifestations

A

Headache visual field defects, often nonsecreting but may secrete GH (acromegaly) and PRL (galactorrhea, erectile dysfunction, decreased libido, amenorrhea)

Nephrolithiasis, bone abnormalities, MSK complaints, symptoms of hypercalcemia

Epigastric pain (peptic ulcers and esophagitis) Hypoglycemia Secretory diarrhea

Rash, anorexia, anemia, diarrhea glossitis

Flushing, diarrhea, bronchospasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

IIa Sipple’s Syndrome tissues involved

A

Thyroid (>90%)
Medullary thyroid cancer (MTC)

Adrenal medulla (40-50%) 
Pheochromocytoma (40-50%)

Parathyroid (10-20%) 1o parathyroid hyperplasia

Skin Cutaneous lichen amyloidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

IIa Sipple’s Syndrome clinical manifestations

A

Physical signs are variable and often subtle

Neck mass or thyroid nodule; non-tender, anterior lymph nodes

HTN, palpitations, headache, sweating

Symptoms of hypercalcemia

Scaly skin rash

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Familial Medullary Thyroid Ca (a variant of IIa) tissues involved

A

Thyroid MTC (≥95%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Familial Medullary Thyroid Ca (a variant of IIa) clinical manifestations

A

MTC without other clinical manifestations of MEN IIa or IIb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MEN IIb tissues involved

A

Thyroid
MTC

Adrenal medulla
Pheochromocytoma (≥50%)

Neurons
Mucosal neuroma, intestinal ganglioneuromas (100%)

MSK (100%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Men IIb clinical manifestations

A

MTC: most common component, more aggressive and earlier onset than MEN IIa HTN, palpitations, headache, sweating

Chronic constipation; megacolon

Marfanoid habitus (no aortic abnormalities)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MEN I investigations

A

■ laboratory
◆ may consider genetic screening for MEN-1 mutation in index patients – if a mutation is identified, screen family members who are at risk
◆ gastrinoma: elevated serum gastrin level (>200 ng/mL) after IV injection of secretin
◆ insulinoma: reduced fasting blood glucose (hypoglycemia) with elevated insulin and C-peptide levels
◆ glucagonoma: elevated blood glucose and glucagon levels
◆ pituitary tumours: assess GH, IGF-1, and prolactin levels (for over-production), TSH, free T4, 8 AM cortisol, LH, FSH, bioavailable testosterone or estradiol (for underproduction due to mass effect of tumour)
◆ hyperparathyroidism: serum Ca2 and albumin, PTH levels; bone density scan (DEXA)

■ imaging
◆ MRI for pituitary tumours, gastrinoma, insulinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MEN II investigations

A

■ laboratory
◆ genetic screening for RET mutations in all index patients – if a mutation is identified, screen family members who are at risk
◆ calcitonin levels (MTC); urine catecholamines and metanephrines (pheochromocytoma); serum Ca2+, albumin, and PTH levels (hyperparathyroidism)
◆ pentagastrin ± calcium stimulation test if calcitonin level is within reference range
◆ FNA for thyroid nodules-cytology

■ imaging
◆ CT or MRI of adrenal glands, metaiodobenzylguanidine (MIBG) scan for pheochromocytoma
◆ octreoscan and/or radionuclide scanning for determining the extent of metastasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment MEN I

A

■ medical
◆ proton pump inhibitor (PPI) for acid hypersecretion in gastrinoma
◆ cabergoline or other dopamine agonists to suppress prolactin secretion
◆ somatostatin for symptomatic carcinoid tumours

■ surgery for hyperparathyroidism, insulinoma, glucagonoma, pituitary tumours (if medical treatment fails for the latter)
◆ trans-sphenoidal approach with prn external radiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment Men II

A

■ surgery for MEN IIa with pre-operative medical therapy
◆ prostaglandin inhibitors to alleviate diarrhea associated with thyroid cancer
◆ α blocker for at least 10-21 d for pheochromocytoma pre-operatively
◆ hydration, calcitonin, IV bisphosphonates for hypercalcemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Normal calcium levels

A
  • normal total serum Ca2+: 2.2-2.6 mmol/L
  • ionic/free Ca2+ levels: 1.15-1.31 mmol/L
  • serum Ca2+ is about 40% protein bound (mostly albumin), 50% ionized, and 10% complexed with PO43- and citrate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What regulates calcium

A

regulated mainly by two factors: parathyroid hormone (PTH) and vitamn D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What organs does calcium act on

A

actions mainly on three organs: GI tract, bone, and kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

PTH: source, regulation of calcium and net effect

A

From parathyroid glands

Regulation - Stimulated by low serum Ca2+ and high serum PO43-;
inhibited by chronic low serum Mg2+, high serum Ca2+, and calcitriol

Net effect
Inc Ca
Inc Calcitriol
Dec PO4

21
Q

Calcitriol (1,25 - (OH)2D3) source, regulation of calcium and net effect

A

Source:
Dietary intake Synthesized from cholesterol: UV on skin makes cholecalciferol (vitD3) liver makes calcidiol (25-(OH)D3) kidneys make calcitriol

Regulation: Renal calcitriol production is stimulated by low serum PO43- and PTH; inhibited by high serum PO43- and calcitriol in negative feedback

Net effect
Inc Ca
Inc PO4

22
Q

Calcitonin source, regulation of calcium and net effect

A

Source: thyroid cells

Regulation: Stimulated by pentagastrin (GI hormone) and high se um Ca2+; inhibited by low serum Ca2+

Net effect
Dec Ca (in pharmacologic doses)
Dec PO4

23
Q

Mg effect

A

Cofactor for PTH secretion

24
Q

PO4 effect

A

Dec Ca

25
Q

Primary hyperparathyroidism definition and etiologies and treatment

A

Increased PTH secretion commonly due to parathyroid adenoma lithium therapy; less often parathyroid carcinoma or parathyroid h perplasia

Most commonly related to a solitary adenoma or less commonly multiple gland hyperplasia. Surgical excision acts as definitive treatment and is recommended for patients who are symptomatic. For mild asymptomatic disease medical surveillance may be appropriate with annual serum calcium, creatinine, and bone mineral density (BMD) For asymptomatic patients surgery is recommended for those who meet ≥1 of the following criteria: • Serum calcium concentration more than 0.25 mmol/L (1.0 mg/dL) above the upper limit of normal • Creatinine clearance <60 mL/min • BMD T-score

26
Q

Secondary hyperparathyroidism definition and etiologies

A

Partial resistance to PTH action leads to parathyroid gland hyperplasia and increased PTH secretion, often in patients with renal failure and osteomalacia (due to low or low normal serum calcium levels)

27
Q

Tertiary hyperparathyroidism definition and etiologies

A

Irreversible clonal outgrowth of parathyroid glands, usually in long-standing inadequately treated chronic renal failure on dialysis

28
Q

Most common cause of hypercalcemia in healthy outpatients

A

Primary hyperparathyroidism

29
Q

Pseudohypercalcemia

A

Increased protein binding leading to an elevation in serum total Ca2+ without a rise in the ionized/free form, e.g. hyperalbuminemia from severe dehydration

30
Q

Parathyroid hormone regulation

A

TN E37

31
Q

Hyperccalcemia definition

A

• total corrected serum Ca2+ >2.6 mmol/L OR ionized Ca2+ >1.35 mmol/L

32
Q

Approach to hypercalcemia

A
  1. Is the patient hypercalcemic (correct for albumin)
  2. Is the PTH high/normal or low?
  3. If PTH is low, is phosphate high/normal or low? If phosphate is high/normal is the level of vitamin D metabolites high or low
33
Q

How to calculate corrected calcium and what different calcium levels indicate

A

Corrected Ca2+ (mmol/L) = measured Ca2++ 0.02 (40 – albumin)

For every decrease in albumin by 10, increase in Ca2+ by 02

Benign (less likely malignant): Ca2+ <2.75 mmol/L)

Pathologic (more likely malignant): Ca2+ >3.25 mmol/L

34
Q

Differential diagnosis of hypercalcemia

A

E38

35
Q

Clinical features of hypercalcemia

A

Symptoms depend on the absolute Ca2+ value and the rate of its rise (may be asymptomatic)

CVS: 
HTN 
Arrhythmia 
Short QT 
Deposition of Ca2+ on valves, coronary arteries, myocardial fibres

GI:
Constipation Anorexia Nausea Vomiting (groans) PUD pancreatitis

Renal:
Polyuria (Nephrogenic DI) Polydipsia Nephrolithiasis (stones) Renal failure (irreversible) Dehydration

Rheumatological:
Gout
Pseudogout Chondrocalcinosis

MSK:
Weakness
Bone pain (bones)

Psychiatric:
>3 mmol/L
Increased alertness Anxiety Depression Cognitive dysfunction Organic brain syndromes
>4 mmol/L (16 mg/dL) Psychosis (moans)

Neurologic:
Hypotonia Hyporeflexia Myopathy Paresis

“Bones, stones, groans and psychiatric overtones”

36
Q

Symptoms of hypercalcemic crisis

A

Usually >4 mmol/L

primary symptoms include oliguria/anuria and mental status changes including somnolence and eventually coma –> this is a medical emergency and should be treated immediately!

37
Q

Hypercalcemia treatment

A
  • treatment depends on the Ca2+ level and the symptoms
  • treat the underlying cause of the hypercalcemia
  • treat acute, symptomatic hypercalcemia aggressively
  • mild asymptomatic hypercalcemia; monitor, avoid: thiazide, volume depletion, high Ca2+ diet, lithium, bed rest
38
Q

What is the most common cause of hypercalcemia in hospital

A

Malignancy - associated hypercalcemia

39
Q

Malignancy - associated hypercalcemia usual presentation and mechanisms

A
  • Usually occurs in the later stages of disease
  • Most commonly seen in lung, renal, breast, ovarian, and squamous tumours, as well as lymphoma and multiple myeloma

Mechanisms:
• Secretion of parathyroid hormone-related protein (PTHrP) which mimics PTH action by preventing renal calcium excretion and activating osteoclast-induced bone resorption

  • Cytokines in multiple myeloma • Calcitriol production by lymphoma
  • Osteolytic bone metastases direct effect
  • Excess PTH in parathyroid cancer
40
Q

Differential diagnosis of hypercalcemia

A
  • Primary hyperparathyroidism
  • Malignancy: hematologic, humoral, skeletal metastases (>90% from 1 or 2)
  • Renal disease: tertiary hyperparathyroidism
  • Drugs: calcium carbonate, milk alkali syndrome, thiazide, lithium, theophylline, vitamin A/D intoxication
  • Familial hypocalciuric hypercalcemia
  • Granulomatous disease: sarcoidosis, TB, Hodgkin’s lymphoma
  • Thyroid disease: thyrotoxicosis
  • Adrenal disease: adrenal insufficiency, pheochromocytoma
  • Immobilization
41
Q

Treatment of acute hypercalcemia/hypercalcemic crisis

A

Increase urinary Ca Excretion:

  1. Isotonic saline (4-5 L) over 24 h ± loop diuretic (e.g. furosemide) but only if hypervolemic (urine output >200mL/h)
  2. Calcitonin: 4 IU/kg IM/SC q12h 8 IU/kg IM/SC q6h Only works for 48 h Rapid onset within 4-6

Diminish bone resorption:
1. Bisphosphonates (treatment of choice)
Inhibits osteoclastic bone resorption and promotes renal excretion of calcium
Acts rapidly but often transient response (decreased by 0.3-0.5 mmol/L beginning within 4-6 h) max effect usually in 7 d
Combination of calcitonin and steroids may prolong reduction in calcium
Tachyphylaxis may occur
Indicated in malignancy-related hypercalcemia (IV pamidronate or zoledronic acid used)
2. Mithramycin (rarely used) – effective when patient cannot tolerate large fluid load
Dangerous – hematotoxic and hepatotoxic

Decrease GI Ca absorption
1. Corticosteroids in hypervitaminosis D and hematologic malignancies
Anti-tumour effects -> decreased calcitriol production by the activated mononuclear cells in lung and lymph node
Slow to act (5-10 d); need high dose

Dialysis
1. Tx of last resort
Indication - severe malignancy - associated hypercalcemia and renal insufficiency or heart failure

42
Q

What deficiency can impair PTH secretion and action

A

Hypomagnesmia

43
Q

Hypocalcemia definition

A

total corrected serum Ca2+ <2.2 mmol/L

44
Q

Clinical features of hypocalcemia

A

Acute hypocalcemia:
Paresthesia (perioral, hands, and feet)
Laryngospasm (with stridor)
Hyperreflexia
Tetany
Chvostek’s sign (tap CN VII just anterior to the external auditory meatus elicits ipsilateral spasm of the orbicularis oculi or orbicularis oris muscles)
Trousseau’s sign (inflation of a blood pressure cuff above systolic pressure for 3 min elicits carpal spasm and paresthesia)
ECG changes
Delirium
Psychiatric Sx: emotional instability, anxiety, and depression

Chronic hypocalcemia:
CNS: lethargy, seizures, psychosis, basal ganglia calcification, Parkinson’s, dystonia, hemiballismus, papilledema, pseudotumour cerebri
CVS: prolonged QT interval g Torsades de pointes (ventricular tachycardia)
GI: steatorrhea
ENDO: impaired insulin release
SKIN: dry, scaling, alopecia, brittle and transversely fissured nails, candidiasis, abnormal dentition
OCULAR: cataracts
MSK: generalized muscle weakness and wasting

45
Q

Differential diagnosis of tetany

A
  • Hypocalcemia
  • Metabolic alkalosis (with hyperventilation)
  • Hypokalemia
  • Hypomagnesemia
46
Q

Approach to hypocalcemia?

A
  1. Is the patient hypocalcemic?
  2. Is the PTH high or low?
  3. If PTH is high, is phosphate low or normal?
  4. Is the Mg2+ level low?
47
Q

Hypocalcemia treatment

A
  • correct underlying disorder
  • treat concurrent hypomagnesemia

• mild and symptomatic (ionized Ca2+ >0.8 mmol/L)
■ treat by increasing dietary Ca2+ by 1000 mg/d
■ calcitriol 0.25 µg/d (especially in renal failure)

acute or symptomatic hypocalcemia (ionized Ca2+ <0.7 mmol/L)
■ immediate treatment required
■ IV calcium gluconate 1-2 g over 10-20 min followed by slow infusion if necessary
■ goal is to raise Ca2+ to low normal range (2.0-2.1 mmol/L) to prevent symptoms but allow maximum stimulation of PTH secretion

  • if PTH recovery not expected requires long-term therapy with calcitriol and calcium
  • do not correct hypocalcemia if asymptomatic and suspected to be transient
48
Q

What is a common complication following subtotal thyroidectomy

A

Transient hypoparathyroidism (resulting in hypocalcemia) common after subtotal thyroidectomy (permanent in <3% of surgeries)

49
Q

Etiology and clinical approach to hypocalcemia

A

E40

Endocrinology (9 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions